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Caffeic acid phenethyl ester, an active component of propolis extract, inhibits Yipoxygenase in the micromolar concentration range. The inhibition 
is of an uncompetitive type, i.e. the inhibitor binds to the enzyme-substrate complex but not to the free enzyme. Caffeic acid phenethyl ester also 
exhibits antioxidant properties. At a concentration of 10 PM, it completely blocks production of reactive oxygen species in human neutrophils and 
the xanthinelxanthine oxidase system. 
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1. INTRODUCTION 
Caffeic acid phenethyl ester (CAPE) is an active com- 
ponent of propolis extracts [l] and has been demon- 
strated to be cytostatic [l-3]. Since arachidonic acid 
metabolites are important mediators in cancer and in- 
flammation we attempted to characterize the anti-lipox- 
ygenase activity of CAPE and compare it with the clas- 
sical lipoxygenase inhibitors, caffeic acid [4] and nor- 
dihydro~aiareti~ acid (NDGA) 151. Keeping in mind 
that the 5-lipoxygenase pathways of arachidonic acid 
oxidation by plant and animal lipoxygenases are simi- 
lar, we used barley 5-lipoxygenase. For the analysis of 
the inhibitory action of CAPE, we utilized a graphical 
method of Yoshino’s [6], which is applicable for partial 
and complete competitive, non-competitive, uncompeti- 
tive and mixed-type inhibition. 
2. MATERIALS AND METHODS 
2.1. Synthesis of CAPE 
Caffeic acid phenethyl ester was synthesized according to Dhaon et 
al. (7’J. The physical constants of the substance obtained &JV (MeOH): 
325 nm (E 118,300), 300 nm (sh., 14,000), 235-245 mn (10,300), melting 
point: 124-12YCl were identical to those reported by Grunberger [I]. 
The chemical structure of CAPE was confmned by ‘H NMR spectra 
(200 MI&z, acetone-d,): 8.52; 8.26 (br.s. 2H, OH), 7.53 (d,J = 16 Hz, 
IH, 7-H),7.35-7.20(m, 5H,l3-17H),7.l7(d, J = 2,d/z, lH,2-H),7.05 
(dd, J = 8.0 Hz, J = 2.0 Hz, lH, 6-H), 6.84 (d, J = 8.0 Hz, lH, 5-H), 
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6.26 (d, J = 16.0 HZ, IH, 8-H), 4.36 (t. J = 7.0 Hz, ZH, IO-H), 3.00 (t, 
J = 7,0 Hz, 2H, 11-H). 
2.2. Isolation of 54poxygenose 
5-Lipoxygenase, with a specific activity of 38 flmol/min/mg, was 
isolated from barley grains, variety Risk, by the method described 
previously [8], with some modifications. After acetone extraction of 
barley flour, the acetone powder was dried and extracted with 50 mM 
sodium phosphate buffer containing 50 mM NaCl. The extract was 
fractionated with ammonium sulfate (30-608) and subjected to CM- 
cellulose (Whatman) and DEAE-Sepharose (Pharmacia) ehromatog- 
raphy. A cohmm (2.6 x 12 cm) of CM-cellulose was equilibrated with 
0.07 M sodium acetate buffer, pH 4.8, and, after application of the 
sample, eluted with a linear gradient of sodium acetate (0.7-0.77 M). 
A column (1.6 x 20 cm) of DEAE-Sepharose was equilibrated with 
0.02 M sodium phosphate buffer, pH 6.8, and, after application of the 
sample, eiuted with a linear gradient of NaCl (O-O.3 M) in the same 
buffer. The fractions containing 5-lipoxygenase were dialyzed against 
water and lyophilized. Dried protein was stored at -20°C. Protein 
concentration was routinely assayed by measuring the absorbance at 
280 nm, and a concentration of 1 mg/ml was attributed to the enzyme 
solution with an absorbance of 1.6 U, i.e. using the extinction coeffi- 
cient for potato 5-lipoxygenase [9], 
2.3. Assay of S-liponygenase activity 
The activity of the enzyme was assayed sp~trophotornet~c~y ac- 
cording to Holman [lo]. The a~um~ation of the product was esti- 
mated from repeated recordings of the chamcte~stic absorption spec- 
tra of fatty acid hydroperoxides (2, = 235 nm) in a Shimadzu UV- 
240 spectrophotometer at2O*C. The identity of the product was con- 
firmed by reverse-phase HPLC, as described elsewhere [l I]. The rate 
of the 5-lipoxygenase-catalyzed formation of 9-hydroperoxy-10,12,15- 
octa-decatrienoic acid from linoleic acid was maximal when the en- 
zyme is added to the substrate quilibrated with the buffer. We ob- 
served that the residual activity, when related to the activity in the 
absence of the inhibitor, is independent of the sequence in which the 
reagents are added. Therefore, the reaction was started by the addition 
of the substrate to the otherwise complete assay mixture. The standard 
reaction mixture contained 0.3-1.5 &ml barley 5-lipoxygenase, 100 
PM ammonium linoleate and 50 mM sodium phosphate, pH 6.8. The 
inhibitors were added to the enzyme as ethanolic solutions, and the 
21 
Volume 329, number 1,2 FEBS LETTERS August 1993 
mixture was preincubated for indicated times before the substrate was 
added. 
2.4. Assay of reactive oxygen species 
The formation of active oxygen by neutrophils stimulated with 
phorbol 12-myristate 13-acetate (PMA) was monitored by measuring 
luminol-enhanced luminescence as described earlier [12]. The neutro- 
phils were isolated from freshly drawn donor blood using a biiayer 
gradient of Ficoll-Paque (1.077 and 1.125 g/ml specific gravity). 
Washed neutrophils were resuspended in bicarbonate-free Hanks’ so- 
lution containing 10 mM HEPES, pH 7.4, and kept at 4°C until use. 
Superoxide (0,J production was assayed by measuring lumines- 
cence in the luminol/xanthine/xanthine oxidase system, as described 
[13]. The rate of 02- formation in this cell-free system was found to 
be affected by CAPE, catfeic acid and NDGA. All the inhibitors tested 
were added to the assay medium containing 50 PM xanthine, 0.1 mM 
EDTA, 1 mM NaN, and 20 mM Na,CO, buffer, pH 10, immediately 
before initiation of the reaction by the addition of xanthine oxidase. 
Chemiluminescence was monitored in a 1251 LKB luminometer, 
using 1 PM luminol. Measurements were made every 30 s over a 30 
min period at 20°C (cell-free system) or 37°C (neutrophils). 
2.5. Chemicals 
Caffeic (3,4-dihydroxycinnamic) acid (Reachim, Latvia) was crys- 
tallized from water. Phenethyl alcohol and 4-(dimethylamino)-pyri- 
dine used for CAPE synthesis were obtained from Fluka. Linoleic 
acid, NDGA, PMA, xanthine and xanthine oxidase were Sigma prod- 
ucts. Ficoll-Paque was from Pharmacia, and dimethylsulfoxide was 
from Merck. 
3. RESULTS AND DISCUSSION 
The purified CAPE prepared in this work was found 
to suppress 5-lipoxygenase-catalyzed oxygenation of li- 
noleic acid (Fig. 1) and arachidonic acid (data not 
shown). This compound was also effective as an inhibi- 
tor of the analogous reactions catalyzed by 15-lipoxyge- 
nase (data not shown). 
There is ample evidence in the literature that caffeic 
acid and its synthetic derivatives can inhibit lipoxyge- 
nases [4,14-l 63. However, the interaction of CAPE with 
these enzymes has not yet been studied. A non-compet- 
itive mechanism of inhibition was postulated for caffeic 
acid [4]. 
The effect of CAPE on 5lipoxygenase kinetics was 
characterized using the spectrophotometrical ssay of 
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Fig. 1. The dose-dependence of 5-lipoxygenase inhibition by CAPE 
and caffeic acid. The inhibitors were added to the enzyme 1 min before 
the substrate (100 FM linoleic acid). 
activity. CAPE suppresses markedly 5lipoxygenase ac- 
tivity after a 1-min incubation. The dose-dependence of 
the residual activity of 5-lipoxygenase preincubated 
with caffeic acid and CAPE is shown in Fig. 1. The 
inhibition is complete as indicated by the linearity of the 
plot and the fact that enzyme activity decreases to zero 
when CAPE is in excess. 
The fractional-velocity plot, V/( I’,--V’), vs. reciprocal 
inhibitor concentration, consists of straight lines inter- 
secting the abscissa t the origin, with the slope decreas- 
ing with increasing substrate concentration (Fig. 2). 
Here, V and V, refer to velocity in the presence and in 
the absence of the inhibitor, respectively, at a given 
concentration of the substrate [6]. Yoshino [6] has 
shown for the Michaelis-Menten mechanism that such 
a pattern is indicative of a complete uncompetitive inhi- 
bition. This inhibition mechanism implies that the in- 
hibitor only combines with the enzyme-substrate com- 
plex but not with the free enzyme, and the resulting 
enzyme-substrate-inhibitor complex is inert. The rate 
data obtained were analyzed in terms of the model 
V U+W<,/[O,1)(1+ WPlNKi’/M+k’~lo 
v,-v = {I+ K;W[WU~ +(~~,~o<,~~~l~>~-~~‘fl<)o+(K,~~~,1~~~+ WWI 
Eqn. 1. 
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Scheme 1. 
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Fig. 2. (A) The fractional-velocity plot for the CAPE inhibition of 
5-lipoxygenase-catalized oxidation of linoleic acid. Linoleic acid con- 
centrations MM): (W) 40; (0) 50; (v) 75; (a) 100. The inhibitor was 
added to the enzyme 1 mm before the substrate. (B) Re-plot of the 
slope of the fractional-velocity plot presented in Fig, 24. 
shown in Scheme 1, where E is active lipoxygenase, Ki, 
K& etc. are dissociation constants for the enzyme-li- 
gand complexes, and /c and k’ are the catalytic constants 
for the breakdown of the ES00 and the ES001 com- 
plexes, respectively. 
Assuming a rapid equilibrium mechanism, one can 
derive the rate equation shown as Eqn. 1. 
That plots of vl( V,- v) vs. l/[IJ are linear and pass 
through the origin at constant oxygen pressure (Fig. 
2A) suggests that K, = co, K,’ = 0 and k’ = 0. The slope 
of the fractional-velocity plot (tg u) is given in Eqn. 2. 
The data shown in Figs. 1 and 2 are consistent with 
a complete uncompetitive in~bi~on of 5-lipoxygenase 
by CAPE. By re-plotting the slopes of the curves in Fig. 
2A vs. substrate concentration (Fig. 2B) and assuming 
K,” = K,‘, one obtains K,” 5 8 PM. The anti-lipoxyge- 
nase activity of CAPE is thus greater than that of caffeic 
acid, though not as high as that of the synthetic caffeic 
acid derivatives described by Yu et al. [14]. 
We have also found that CAPE decreases the chemi- 
luminescence af PMA-stimulated neutrophils (Fig. 3) 
and of a cell-free superoxide-generating xantbinelxan- 
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Fig. 3. Effect of CAPE on the luminol-enhanced chemiluminescence 
produced by human neutrophils (2 x IO6 per ml) stimulated with 0.5 
&ml PMA. At the indicated time 10 FM CAPE (curve 2) or equal 
volume (6 ~1) of ethanol (curve 1) was added. 
thine oxidase enzyme system (Fig. 4). The effectiveness 
of CAPE and caffeic acid as lipoxygenase inhibitors 
correlates with their redox properties (Figs. 1 and 4)). 
The complete uncompetitive type of 5-lipoxygenase in- 
hibition by CAPE is consistent with CAPE being a non- 
specific antioxidant. One can expect inhibitors with an- 
tioxidant properties, like CAPE, to combine with a 
broad range of reactive enzyme-ligand intermediates 
with concomitant trapping of radical intermediates. In 
the reaction mechanism proposed for 15-lipoxygenase 
[ 171, enzyme-bound peroxyl and pentadienyl radicals 
were identified as the intermediates leading to the hy- 
droperoxide products [ 18f. Based on the reaction mech- 
anism of 15-lipoxygenase, one may speculate that the 
antioxidant inhibitors block the reduction of the per- 
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Fig. 4. The effects of CAPE, caffeic acid and NDGA on the lumlnol- 
enhanced chemiluminescence produced by the cell-free xanthine/xan- 
thine oxidase system. The indicated concentrations of the inhibitors 
or 3 ~1 of ethanol (control) were added 10 s before initiation of the 
reaction by xanthine oxidase (XOD). 
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oxyl radical by Fe(I1) and, therefore, formation of the 
activated Fe(II1) form of the enzyme and fatty acid 
peroxide. 
The studies described here demonstrate the ability of 
CAPE to inhibit 5-lipoxygenase by a complete uncom- 
petitive mechanism. One may conclude that CAPE is an 
antioxidant-based lipoxygenase inhibitor the antioxi- 
dant potency of which slightly exceeds that of NDGA. 
Thus, CAPE may contribute to the anti-inflammatory 
activity of propolis in vivo by being both a lipoxygenase 
inhibitor and an antioxidant. 
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